Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 EUR | -.--% | +1.68% | +30.11% |
Apr. 03 | Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2024 * | 4.58M 4.96M | Sales 2025 * | - | Capitalization | 16.3M 17.68M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.79 x |
Net Debt 2024 * | 1.03M 1.12M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
22
x | P/E ratio 2025 * |
-
| Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.94% |
1 week | +1.68% | ||
1 month | +2.54% | ||
3 months | +23.47% | ||
6 months | +21.61% | ||
Current year | +30.11% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Jané Font
CEO | Chief Executive Officer | - | 08-12-31 |
Chief Executive Officer | - | 08-12-31 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 08-12-31 | |
Albert Jané Font
CEO | Chief Executive Officer | - | 08-12-31 |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.42 | -.--% | 1,500 |
24-05-30 | 2.42 | -.--% | 0 |
24-05-29 | 2.42 | +1.68% | 32,803 |
24-05-28 | 2.38 | -.--% | 0 |
24-05-27 | 2.38 | -.--% | 0 |
Delayed Quote BME, May 31, 2024 at 10:00 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.11% | 17.68M | |
-27.23% | 222M | |
+30.98% | 73.37M | |
-23.50% | 66.34M |
- Stock Market
- Equities
- VYT Stock